Importance of patient orientation and reusability as components of intensive care unit sedation

International Congress and Symposium Series - Royal Society of Medicine

Volumn , Issue 221, 1998, Pages 23-29

  Mantz, Jean ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4644322491     PISSN: 01422367     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (17)

1. Shapiro BA, Warren J, Egol AB et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med 1995; 23: 1596600.
2. Xlth Consensus Conference on Reanimation and Emergency Medicine. Sedation and réanimation concept and practice. Re'an Urg 1993; 2: 437-51.
3. Bion JF, Ledingham IM. Sedation in the intensive care unit -a postal survey. Intensive Care Med 1987; 13:215-16.
4. Ramsay M, Savege T, Simpson B, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ 1974; 2: 656-9.
5. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998: 26: 947-56.
6. Weinbroum AA, Halpern P, Rudick V et al. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med 1997; 23: 1258-63.
7. Maxwell C. Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol 1978; 6: 15-24.
8. Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997; 85: 1136-42.
9. Aantaa R, Kallio A, Virtanen R. Dexmedetomidine, a novel ocdrenergic agonist. A review of its pharmacodynamic characteristics. Drugs Future 1993; 18: 49-56.
10. Sirviö J, Mazurkiewicz M, Haapalinna A et al. The effects of selective adrenergic agents on the performance of rats in a 5-choice serial reaction time task. Brain Res Bull 1994; 35: 451-5.
11. Ruotsalainen S, Haapalinna A, Riekkinen PJ Sr et al. Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and shortterm memory tasks. Pbarmacol Biocbem Behav 1997; 56: 31-40.
12. Aantaa R. Assessment of the sedative effects of dexmedetomidine, an oc2-adrenoceptor agonist, with analysis of saccadic eye movements. Pharmacol Toxicol 1991; 68: 394-8.
13. Hannington-Kiff JG. Measurement of recovery from outpatient general anaesthesia with a simple ocular test. BMJ 1970; 3: 132-5.
14. Smith JM, Misiak H. Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects -a review. Psychopharmacology 1976; 47: 175-82.
15. Griffiths AN, Marshall RW, Richens A. Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance. BrJ Clin Pharmacol 1984; 18(suppl): 73S-82S.
16. Cheng EY. Recall in the sedated ICU patient. J ClinAnesth 1996; 8: 675-8.
17. Aho MS, Erkola OA, Scheinin H et al. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg 1991; 73: 112-18.